How to Get Breyanzi (lisocabtagene maraleucel) Covered by Cigna in New Jersey: Prior Authorization, Appeals, and Medical Necessity Requirements
Answer Box: Getting Breyanzi Covered by Cigna in New Jersey
Cigna covers Breyanzi (lisocabtagene maraleucel) for FDA-approved indications with prior authorization required. Key eligibility: adults with relapsed/refractory large B-cell lymphoma after ≥2 prior lines, or CLL/SLL after ≥2 lines including BTK and BCL-2 inhibitors. Fastest path to approval: